Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: Phase 3, Randomized, Placebo-Controlled, ZOE-HSCT Clinical Trial

被引:0
|
作者
Sullivan, Keith [1 ]
Abhyankar, Sunil [2 ]
Campora, Laura [3 ]
Cellini, Claudia [4 ]
Chandrasekar, Pranatharthi [5 ]
de la Serna, Javier [6 ]
El Idrissi, Mohamed [3 ]
Gaidano, Gianluca [7 ]
Issa, Nicolas [8 ,9 ]
Lee, Je-Jung [10 ]
Fauqued, Marta Lopez [3 ]
Lopez Jimenez, Javier [11 ]
Oostvogels, Lidia [3 ]
Pohlreich, David [12 ]
Quittet, Philippe [13 ]
Schwartz, Stefan [14 ]
Stadtmauer, Edward [15 ]
Szer, Jeff [16 ]
Bastidas, Adriana [3 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Univ Kansas, Ctr Canc, Westwood, KS USA
[3] GSK, Wavre, Belgium
[4] Hosp Santa Maria delle Croci, Ravenna, Italy
[5] Wayne State Univ, Detroit, MI USA
[6] Hosp Univ 12 Octubre, Madrid, Spain
[7] Univ Piemonte Orientale, Novara, Italy
[8] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
[10] Chonnam Natl Univ, Hwasun Hosp, Jellanamdo, South Korea
[11] Ramon & Cajal Hosp, Madrid, Spain
[12] Charles Univ Hosp, Prague, Czech Republic
[13] Univ Hosp Montpellier, Montpellier, France
[14] Charite Univ Med Ctr, Berlin, Germany
[15] Univ Penn, Philadelphia, PA 19104 USA
[16] Royal Melbourne Hosp, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O111
引用
收藏
页码:95 / 97
页数:3
相关论文
共 50 条
  • [31] Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
    Abarca, Katia
    Rey-Jurado, Emma
    Munoz-Durango, Natalia
    Vazquez, Yaneisi
    Soto, Jorge A.
    Galvez, Nicolas M. S.
    Valdes-Ferrada, Javier
    Iturriaga, Carolina
    Urzua, Marcela
    Borzutzky, Arturo
    Cerda, Jaime
    Villarroel, Luis
    Madrid, Victoria
    Gonzalez, Pablo A.
    Gonzalez-Aramundiz, Jose, V
    Bueno, Susan M.
    Kalergis, Alexis M.
    ECLINICALMEDICINE, 2020, 27
  • [32] Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial
    Li, Yan-Ping
    Liang, Zheng-Lun
    Gao, Qiang
    Huang, Li-Rong
    Mao, Qun-Ying
    Wen, Shu-Qun
    Liu, Yan
    Yin, Wei-Dong
    Li, Rong-Cheng
    Wang, Jun-Zhi
    VACCINE, 2012, 30 (22) : 3295 - 3303
  • [33] A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults
    Keech, Cheryl A.
    Morrison, Royce
    Anderson, Porter
    Tate, Andrea
    Flores, Jorge
    Goldblatt, David
    Briles, David
    Hural, John
    Malley, Richard
    Alderson, Mark R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (04) : 345 - 351
  • [34] A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL EVALUATING SAFETY AND EFFICACY OF LETERMOVIR PROPHYLAXIS EXTENDED FROM 100 TO 200 DAYS POST-TRANSPLANT IN CYTOMEGALOVIRUS-SEROPOSITIVE ALLOGENEIC HSCT RECIPIENTS
    Russo, Domenico
    Dadwal, Sanjeet S.
    Stelljes, Matthias
    Schmit, Michael
    Pilorge, Sylvain
    Teal, Valerie L.
    Haber, Barbara
    Bopp, Charlene
    Badshah, Cyrus
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 86 - 87
  • [35] Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations
    Tabarsi, Payam
    Anjidani, Nassim
    Shahpari, Ramin
    Mardani, Masoud
    Sabzvari, Araz
    Yazdani, Babak
    Roshanzamir, Khashayar
    Bayatani, Behnam
    Taheri, Ali
    Petrovsky, Nikolai
    Li, Lei
    Barati, Saghar
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (09) : 1263 - 1271
  • [36] A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicity
    Wu, Jin-Yuan
    Zhang, Wei
    Pu, Jing
    Liu, Yan
    Huang, Li-Li
    Zhou, Yan
    Gao, Jia-Mei
    Tan, Jie-Bing
    Liu, Xin-Ling
    Yang, Jing
    Lin, Xiao-Chen
    Feng, Guang-Wei
    Yin, Na
    Chen, Rong
    Hu, Xiao-Qing
    Yi, Shan
    Ye, Jun
    Kuang, Xiang-Jing
    Wang, Yan
    Zhang, Guang-Ming
    Sun, Mao-Sheng
    Wang, Yan-Xia
    Hu, Zhong-Yu
    Yang, Jing-Si
    Li, Hong-Jun
    VACCINE, 2024, 42 (19) : 4030 - 4039
  • [37] Posoleucel for the prevention of clinically significant infections in high-risk allogeneic hematopoietic cell transplant recipients: Design of a phase 2/3, randomized, double-blind, placebo-controlled trial
    Sica, S.
    Besley, C.
    Boundy, K.
    Matzko, M.
    Tripkovic, N.
    Socie, G.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 280 - 281
  • [38] Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Liu, Jiankai
    Huang, Baoying
    Li, Guifan
    Chang, Xianyun
    Liu, Yafei
    Chu, Kai
    Hu, Jialei
    Deng, Yao
    Zhu, Dandan
    Wu, Jingliang
    Zhang, Li
    Wang, Meng
    Huang, Weijin
    Pan, Hongxing
    Tan, Wenjie
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (10): : 1701 - 1709
  • [39] Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial
    Nurdin, Asrawati
    Nency, Yetty Movieta
    Maddeppungeng, Martira
    Sekartini, Rini
    Sari, Rini Mulia
    Surachman, Fikrianti
    Yani, Finny Fitry
    Raveinal
    Anggrainy, Fenty
    Hafiz, Al
    Linosefa
    Machmud, Rizanda
    Deza, Putri Awaliyah
    Rujiana, Vovinda
    Rahimi, Martga Bella
    Farhanah, Nur
    Pramudo, Setyo Gundi
    Hapsari, Rebriarina
    Anantyo, Dimas Tri
    Mulyono
    Mahati, Endang
    Maharani, Nani
    Darma, Sidrah
    Darussalam, Andi Husni Esa
    Shakinah, Sharifah
    Massi, Muhammad Nasrum
    Soedjatmika
    VACCINE, 2024, 42 (12) : 3009 - 3017
  • [40] A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
    Chemaly, Roy F.
    Dadwal, Sanjeet S.
    Bergeron, Anne
    Ljungman, Per
    Kim, Yae-Jean
    Cheng, Guang-Shing
    Pipavath, Sudhakar N.
    Limaye, Ajit P.
    Blanchard, Elodie
    Winston, Drew J.
    Stiff, Patrick J.
    Zuckerman, Tsila
    Lachance, Silvy
    Rahav, Galia
    Small, Catherine B.
    Mullane, Kathleen M.
    Patron, Roberto L.
    Lee, Dong-Gun
    Hirsch, Hans H.
    Waghmare, Alpana
    McKevitt, Matt
    Jordan, Robert
    Guo, Ying
    German, Polina
    Porter, Danielle P.
    Gossage, David L.
    Watkins, Timothy R.
    Marty, Francisco M.
    Chien, Jason W.
    Boeckh, Michael
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (11) : 2777 - 2786